Literature DB >> 35365289

Arrhythmic Recurrence and Outcomes in Patients Hospitalized With First Episode of Electrical Storm.

Juan Ignacio Damonte1, Marco Giuseppe Del Buono2, Georgia K Thomas3, James Mbualungu3, Bennett Clark3, Rocco Antonio Montone4, Daniel H Berrocal5, Tamas S Gal6, Le Kang7, Juan Lu8, Benjamin Van Tassell9, Jayanthi Koneru3, Thomas C Crawford10, Kenneth A Ellenbogen3, Antonio Abbate11, Jordana Kron12.   

Abstract

Electrical storm (ES) is a life-threatening condition that may lead to recurrent arrhythmias, need for ventricular mechanical support, and death. The study aimed to assess the burden of arrhythmia recurrence and in-hospital outcomes of patients admitted for ES in a large urban hospital. We performed a retrospective analysis of patients admitted with ventricular arrhythmias from January 2018 to June 2021 and identified 61 patients with ES, defined as 3 or more episodes of ventricular tachycardia (VT) or ventricular fibrillation (VF) within 24 hours. We reviewed the in-hospital outcomes and compared outcomes between patients who had no recurrence of VT/VF after the first 24 hours (34 [56%]), those with recurrence of 1 or 2 episodes of VT/VF within a 24-hour period (15 [24%]), and patients with 3 or more recurrent VT/VF events consistent with recurrent ES after the first 24 hours (12 [20%]). Patients with recurrent ES had significantly higher in-hospital mortality as compared with those with recurrent VT/VF not meeting criteria for ES or no recurrences of VT/VF (3 [25%] vs 0 [0%] vs 0 [0%]; p = 0.002). Moreover, patients with recurrent ES also had higher rates of the combined end points of ventricular mechanical support and death (7 [58%] vs 1 [6%] vs 1 [3%], p <0.001), invasive mechanical ventilation and death (10 [83%] vs 2 [13%] vs 2 [6%], p <0.001), catheter ablation or death (12 [100%] vs 7 [47%] vs 12 [35%], p <0.001) and heart transplantation and death (3 [25%] vs 2 [13%] vs 0 [0%], p = 0.018). In conclusion, patients admitted with ES have a high risk of in-hospital recurrence, associated with extremely poor outcomes.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35365289      PMCID: PMC9386621          DOI: 10.1016/j.amjcard.2022.02.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   3.133


  27 in total

1.  Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study).

Authors:  Antonio Abbate; Michael C Kontos; John D Grizzard; Giuseppe G L Biondi-Zoccai; Benjamin W Van Tassell; Roshanak Robati; Lenore M Roach; Ross A Arena; Charlotte S Roberts; Amit Varma; Christopher C Gelwix; Fadi N Salloum; Andrea Hastillo; Charles A Dinarello; George W Vetrovec
Journal:  Am J Cardiol       Date:  2010-04-02       Impact factor: 2.778

Review 2.  Potential proarrhythmic effects of biventricular pacing.

Authors:  Jeffrey M Fish; Josep Brugada; Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2005-12-20       Impact factor: 24.094

3.  Characteristics and Outcomes in Patients With Electrical Storm.

Authors:  Elżbieta Gadula-Gacek; Mateusz Tajstra; Jacek Niedziela; Łukasz Pyka; Mariusz Gąsior
Journal:  Am J Cardiol       Date:  2019-02-25       Impact factor: 2.778

4.  Leukocyte activity in patients with ST-segment elevation acute myocardial infarction treated with anakinra.

Authors:  Chiara Sonnino; Sanah Christopher; Claudia Oddi; Stefano Toldo; Raquel Appa Falcao; Ryan D Melchior; George H Mueller; Nayef A Abouzaki; Amit Varma; Michael L Gambill; Benjamin W Van Tassell; Charles A Dinarello; Antonio Abbate
Journal:  Mol Med       Date:  2014-11-18       Impact factor: 6.354

5.  Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Jin Joo Park; Ho-Joon Jang; Il-Young Oh; Chang-Hwan Yoon; Jung-Won Suh; Young-Seok Cho; Tae-Jin Youn; Goo-Yeong Cho; In-Ho Chae; Dong-Ju Choi
Journal:  Am J Cardiol       Date:  2012-12-27       Impact factor: 2.778

6.  Association of Neutrophil-to-Lymphocyte Ratio With Mortality and Cardiovascular Disease in the Jackson Heart Study and Modification by the Duffy Antigen Variant.

Authors:  Stephanie Kim; Melissa Eliot; Devin C Koestler; Wen-Chih Wu; Karl T Kelsey
Journal:  JAMA Cardiol       Date:  2018-06-01       Impact factor: 14.676

7.  Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.

Authors:  François Brigadeau; Claude Kouakam; Didier Klug; Christelle Marquié; Alain Duhamel; Frédérique Mizon-Gérard; Dominique Lacroix; Salem Kacet
Journal:  Eur Heart J       Date:  2006-01-18       Impact factor: 29.983

Review 8.  Usefulness of Neutrophil/Lymphocyte Ratio as a Predictor of Atrial Fibrillation: A Meta-analysis.

Authors:  Qingmiao Shao; Kangyin Chen; Seung-Woon Rha; Hong-Euy Lim; Guangping Li; Tong Liu
Journal:  Arch Med Res       Date:  2015-05-14       Impact factor: 2.235

9.  Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications.

Authors:  S C Credner; T Klingenheben; O Mauss; C Sticherling; S H Hohnloser
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

10.  Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction.

Authors:  Marco Giuseppe Del Buono; Juan Ignacio Damonte; Cory R Trankle; Dinesh Kadariya; Salvatore Carbone; Georgia Thomas; Jeremy Turlington; Roshanak Markley; Justin M Canada; Giuseppe G Biondi-Zoccai; Michael C Kontos; Benjamin W Van Tassell; Antonio Abbate
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.